CFR scholars provide expert analysis and commentary on international issues. President Donald Trump announced on December 8 that the United States would allow Nvidia to sell its powerful H200 chip—a ...
TAMPA, Fla. and LONDON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today ...
BEIJING, Dec 12 (Reuters) - The world's largest steel producer, China, plans to roll out a licence system from 2026 to regulate exports of the metal, as robust shipments have fuelled a growing ...
* Total program cost including tuition and required fees ‡ Percent of those seeking jobs who accepted employment within 3 months of graduation Taking advantage of its location in one of North ...
Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical models, potentially addressing one of the most lethal cancers with the lowest ...
Preclinical data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα, strongly inhibits pAKT signaling in tumor cells without inducing hyperglycemia, and shows robust anti-tumor activity ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback